Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Growth dynamics of lung nodules: implications for classification in lung cancer screening

  • Ocaña-Tienda, Beatriz
  • Pérez-Beteta, Julián
  • Arana, Estanislao
  • Pérez-García, Victor M.
  • Eroles-Simó, Alba
[EN] Background: Lung nodules observed in cancer screening are believed to grow exponentially, and their associated volume doubling time (VDT) has been proposed for nodule classification. This retrospective study aimed to elucidate the growth dynamics of lung nodules and determine the best classification as either benign or malignant. Methods: Data were analyzed from 180 participants (73.7% male) enrolled in the I-ELCAP screening program (140 primary lung cancer and 40 benign) with three or more annual CT examinations before resection. Attenuation, volume, mass and growth patterns (decelerated, linear, subexponential, exponential and accelerated) were assessed and compared as classification methods. Results: Most lung cancers (83/140) and few benign nodules (11/40) exhibited an accelerated, faster than exponential, growth pattern. Half (50%) of the benign nodules versus 26.4% of the malignant ones displayed decelerated growth. Differences in growth patterns allowed nodule malignancy to be classified, the most effective individual variable being the increase in volume between two-year-interval scans (ROC-AUC = 0.871). The same metric on the first two follow-ups yielded an AUC value of 0.769. Further classification into solid, part-solid or non-solid, improved results (ROC-AUC of 0.813 in the first year and 0.897 in the second year). Conclusions: In our dataset, most lung cancers exhibited accelerated growth in contrast to their benign counterparts. A measure of volumetric growth allowed discrimination between benign and malignant nodules. Its classification power increased when adding information on nodule compactness. The combination of these two meaningful and easily obtained variables could be used to assess malignancy of lung cancer nodules., This work was partially supported by project PDC2022-133520-I00 funded by Ministerio de Ciencia e Innovación/ Agencia Estatal de investigación (doi:https://doi.org/10.13039/501100011033) and European Union NextGenerationEU/PRTR , partially supported by project SBPLY/21/180501/000145, partially funded by Junta de Comunidades de Castilla-La Mancha, Spain (and European Regional Development Fund (FEDER, EU), and partially supported by University of Castilla-La Mancha / FEDER (Applied Research Projects) under grant 2022-GRIN-34405. BOT is supported by Ministerio de Ciencia e Innovación (grant PRE2020-092178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publication Artículo científico (JournalArticle)

Computational flow cytometry immunophenotyping at diagnosis is unable to predict relapse in childhood B-cell Acute Lymphoblastic Leukemia

  • Martínez Rubio, Álvaro
  • Chulian García, Salvador
  • Niño López, Ana del Rosario
  • Picón González, Rocío
  • Rodríguez Gutiérrez, Juan Francisco
  • Gálvez de la Villa, Eva
  • Caballero-Velázquez, Teresa
  • Molinos Quintana, Águeda
  • Castillo Robleda, Ana
  • Ramírez Orellana, Manuel
  • Martínez-Sánchez, María V.
  • Minguela Puras, Alfredo
  • Fuster Soler, José Luis
  • Blázquez Goñi, Cristina
  • Pérez-García, Víctor M.
  • Rosa Durán, María
B-cell Acute Lymphoblastic Leukemia is the most prevalent form of childhood cancer, with approximately 15% of patients undergoing relapse after initial treatment. Further advancements depend on novel therapies and more precise risk stratification criteria. In the context of computational flow cytometry and machine learning, this paper aims to explore the potential prognostic value of flow cytometry data at diagnosis, a relatively unexplored direction for relapse prediction in this disease. To this end, we collected a dataset of 252 patients from three hospitals and implemented a comprehensive pipeline for multicenter data integration, feature extraction, and patient classification, comparing the results with existing algorithms from the literature. The analysis revealed no significant differences in immunophenotypic patterns between relapse and non-relapse patients and suggests the need for alternative approaches to handle flow cytometry data in relapse prediction.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Growth dynamics of lung nodules: implications for classification in lung cancer screening

  • Ocaña-Tienda, Beatriz
  • Eroles-Simó, Alba
  • Pérez-Beteta, Julián
  • Arana, Estanislao
  • Pérez-García, Víctor M.
Background: Lung nodules observed in cancer screening are believed to grow exponentially, and their associated volume doubling time (VDT) has been proposed for nodule classification. This retrospective study aimed to elucidate the growth dynamics of lung nodules and determine the best classification as either benign or malignant., Methods: Data were analyzed from 180 participants (73.7% male) enrolled in the I-ELCAP screening program (140 primary lung cancer and 40 benign) with three or more annual CT examinations before resection. Attenuation, volume, mass and growth patterns (decelerated, linear, subexponential, exponential and accelerated) were assessed and compared as classification methods., Results: Most lung cancers (83/140) and few benign nodules (11/40) exhibited an accelerated, faster than exponential, growth pattern. Half (50%) of the benign nodules versus 26.4% of the malignant ones displayed decelerated growth. Differences in growth patterns allowed nodule malignancy to be classified, the most effective individual variable being the increase in volume between two-year-interval scans (ROC-AUC = 0.871). The same metric on the first two follow-ups yielded an AUC value of 0.769. Further classification into solid, part-solid or non-solid, improved results (ROC-AUC of 0.813 in the first year and 0.897 in the second year)., Conclusions: In our dataset, most lung cancers exhibited accelerated growth in contrast to their benign counterparts. A measure of volumetric growth allowed discrimination between benign and malignant nodules. Its classification power increased when adding information on nodule compactness. The combination of these two meaningful and easily obtained variables could be used to assess malignancy of lung cancer nodules., This work was partially supported by project PDC2022-133520-I00 funded by Ministerio de Ciencia e Innovación/ Agencia Estatal de investigación (doi:https://doi.org/10.13039/501100011033) and European Union “NextGenerationEU/PRTR”, partially supported by project SBPLY/21/180501/000145, partially funded by Junta de Comunidades de Castilla-La Mancha, Spain (and European Regional Development Fund (FEDER, EU), and partially supported by University of Castilla-La Mancha / FEDER (Applied Research Projects) under grant 2022-GRIN-34405. BOT is supported by Ministerio de Ciencia e Innovación (grant PRE2020-092178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Computational flow cytometry immunophenotyping at diagnosis is unable to predict relapse in childhood B-cell Acute Lymphoblastic Leukemia

  • Martínez-Rubio, Álvaro
  • Chulián, Salvador
  • Niño-López, Ana
  • Picón-González, Rocío
  • Rodríguez Gutiérrez, Juan F.
  • Gálvez de la Villa, Eva
  • Caballero Velázquez, Teresa
  • Molinos-Quintana, A.
  • Castillo-Robleda, Ana
  • Ramírez Orellana, Manuel
  • Martínez Sánchez, María Victoria
  • Minguela Puras, Alfredo
  • Fuster Soler, José Luis
  • Blázquez Goñi, Cristina
  • Pérez-García, Víctor M.
  • Rosa, María
B-cell Acute Lymphoblastic Leukemia is the most prevalent form of childhood cancer, with approximately 15% of patients undergoing relapse after initial treatment. Further advancements depend on novel therapies and more precise risk stratification criteria. In the context of computational flow cytometry and machine learning, this paper aims to explore the potential prognostic value of flow cytometry data at diagnosis, a relatively unexplored direction for relapse prediction in this disease. To this end, we collected a dataset of 252 patients from three hospitals and implemented a comprehensive pipeline for multicenter data integration, feature extraction, and patient classification, comparing the results with existing algorithms from the literature. The analysis revealed no significant differences in immunophenotypic patterns between relapse and non-relapse patients and suggests the need for alternative approaches to handle flow cytometry data in relapse prediction., This work was partially supported by project PDC2022-133520-I00 funded by Ministerio de Ciencia e Innovación/ Agencia Estatal de investigación (doi:10.13039/501100011033) and European Union NextGenerationEU/PRTR; by project PID2022-140451OA-I00 funded by Ministerio de Ciencia e Innovación/Agencia Estatal de investigación (doi:10.13039/501100011033) and ERDF A way of making Europe; and by University of Castilla-La Mancha/ERDF, A way of making Europe (Applied Research Projects) under grant 2022-GRIN-34405. The support of Fundación Española para la Ciencia y la Tecnología (FECYT project PR214), Asociación Pablo Ugarte (APU, Spain) and Junta de Andalucía (Spain) group FQM-201 is also acknowledged. This work was also subsidized in its early stages by a grant for the research and biomedical innovation in the health sciences within the framework of the Integrated Territorial Initiative (ITI) for the province of Cádiz (grant number ITI-0038-2019)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression

  • Molina, Oscar|||0000-0001-7585-4519
  • Ortega-Sabater, C.
  • Thampi, Namitha|||0000-0001-6166-583X
  • Fernández Fuentes, Narcís|||0000-0002-6421-1080
  • Guerrero Murillo, Mercedes|||0000-0002-5556-2460
  • Martínez Moreno, Alba|||0000-0001-7514-260X
  • Vinyoles, Meritxell|||0000-0003-1906-4701
  • Velasco-Hernández, Talia|||0000-0003-2183-7443
  • Bueno, Clara|||0000-0003-1442-6216
  • Trincado Alonso, Juan Luis, 1987-|||0000-0001-5363-3774
  • Granada, Isabel|||0000-0002-4275-0104
  • Campos, Diana
  • Giménez, Carles
  • Boer, Judith M.|||0000-0003-4848-7789
  • den Boer, Monique L.
  • Calvo, Gabriel F.|||0000-0002-3623-236X
  • Camós, Mireia|||0000-0003-3658-7942
  • Fuster, José Luis|||0000-0002-4881-9440
  • Velasco Puyo, Pablo|||0000-0001-7331-9483
  • Ballerini, Paola
  • Locatelli, Franco|||0000-0002-7976-3654
  • Mullighan, Charles G.|||0000-0002-1871-1850
  • Spierings, Diana C.J.|||0000-0001-8403-474X
  • Foijer, Floris|||0000-0003-0989-3127
  • Pérez-García, Víctor M.|||0000-0002-6575-495X
  • Menéndez Bujan, Pablo|||0000-0001-9372-1007
Chromosomal instability (CIN) lies at the core of cancer development leading to aneuploidy, chromosomal copy-number heterogeneity (chr-CNH) and ultimately, unfavorable clinical outcomes. Despite its ubiquity in cancer, the presence of CIN in childhood B-cell acute lymphoblastic leukemia (cB-ALL), the most frequent pediatric cancer showing high frequencies of aneuploidy, remains unknown. Here, we elucidate the presence of CIN in aneuploid cB-ALL subtypes using single-cell whole-genome sequencing of primary cB-ALL samples and by generating and functionally characterizing patient-derived xenograft models (cB-ALL-PDX). We report higher rates of CIN across aneuploid than in euploid cB-ALL that strongly correlate with intraclonal chr-CNH and overall survival in mice. This association was further supported by in silico mathematical modeling. Moreover, mass-spectrometry analyses of cB-ALL-PDX revealed a "CIN signature" enriched in mitotic-spindle regulatory pathways, which was confirmed by RNA-sequencing of a large cohort of cB-ALL samples. The link between the presence of CIN in aneuploid cB-ALL and disease progression opens new possibilities for patient stratification and offers a promising new avenue as a therapeutic target in cB-ALL treatment.